Hilleman CEO Moving On, Hands Baton To Ex-Takeda Executive
Executive Summary
Hilleman CEO Davinder Gill is leaving the global vaccine R&D organization after eight years at the helm and several mileposts. Incoming CEO Raman Rao takes charge from 1 February.